TFAP2A and chronic myelogenous leukemia, BCR-ABL1 positive: Transcription factor AP-2 alpha (TFAP2A) and Early B-Cell Factor 2 (EBF2) were identified as epigenetic molecular markers in Acute lymphoblastic leukemia (ALL) and CML-BP.